238 related articles for article (PubMed ID: 23206896)
21. Successful management of severe diabetic ketoacidosis in a patient with type 2 diabetes with insulin allergy: a case report.
Nguyen AD; Luong CQ; Chu HC; Nguyen VKD; Nguyen CV; Nguyen TA; Nguyen QH; Mai TD; Nguyen DV; Nguyen BQ; Tran TH; Dao PV; Nguyen DT; Nguyen NN; Do SN
BMC Endocr Disord; 2019 Nov; 19(1):121. PubMed ID: 31711488
[TBL] [Abstract][Full Text] [Related]
22. [Insulin-induced lipoatrophy in children].
Niinikoski H; Näntö-Salonen K; Ruusu P; Kinnala A; Putto-Laurila A; Toppari J; Keskinen P
Duodecim; 2010; 126(11):1328-32. PubMed ID: 20681357
[TBL] [Abstract][Full Text] [Related]
23. Frequency of dermatological side effects of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes.
Binder E; Lange O; Edlinger M; Meraner D; Abt D; Moser C; Steichen E; Hofer SE
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):260-4. PubMed ID: 25607337
[TBL] [Abstract][Full Text] [Related]
24. [Insulin allergy: background, diagnosis and treatment].
Wonders J; Eekhoff EM; Heine R; Bruynzeel DP; Rustemeyer T
Ned Tijdschr Geneeskd; 2005 Dec; 149(50):2783-8. PubMed ID: 16385830
[TBL] [Abstract][Full Text] [Related]
25. Substitution of night-time continuous subcutaneous insulin infusion therapy for bedtime NPH insulin in a multiple injection regimen improves counterregulatory hormonal responses and warning symptoms of hypoglycaemia in IDDM.
Kanc K; Janssen MM; Keulen ET; Jacobs MA; Popp-Snijders C; Snoek FJ; Heine RJ
Diabetologia; 1998 Mar; 41(3):322-9. PubMed ID: 9541173
[TBL] [Abstract][Full Text] [Related]
26. [The use of continuous subcutaneous insulin infusion (CSII) with personal insulin pumps in the treatment of children and adolescents with diabetes type 1].
Jarosz-Chobot P
Wiad Lek; 2004; 57(5-6):263-6. PubMed ID: 15518073
[TBL] [Abstract][Full Text] [Related]
27. Lipoatrophic diabetes mellitus treated by continuous subcutaneous insulin infusion.
Meyer L; Hadjadj S; Guerci B; Delbachian I; Ziegler O; Drouin P
Diabetes Metab; 1998 Dec; 24(6):544-6. PubMed ID: 9932222
[TBL] [Abstract][Full Text] [Related]
28. Sustained metabolic control and low rates of severe hypoglycaemic episodes in preschool diabetic children treated with continuous subcutaneous insulin infusion.
Pańkowska E; Szypowska A; Lipka M; Skórka A
Acta Paediatr; 2007 Jun; 96(6):881-4. PubMed ID: 17537017
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin.
Sola-Gazagnes A; Pecquet C; Radermecker R; Piétri L; Elgrably F; Slama G; Sélam JL
Diabetes Care; 2003 Oct; 26(10):2961-2. PubMed ID: 14514615
[No Abstract] [Full Text] [Related]
30. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
31. Benefits of continuous subcutaneous insulin infusion (CSII) therapy in preschool children.
Levy-Shraga Y; Lerner-Geva L; Modan-Moses D; Graph-Barel C; Mazor-Aronovitch K; Boyko V; Pinhas-Hamiel O
Exp Clin Endocrinol Diabetes; 2013 Apr; 121(4):225-9. PubMed ID: 23329580
[TBL] [Abstract][Full Text] [Related]
32. Cessation of insulin infusion at night-time during CSII-therapy: comparison of regular human insulin and insulin lispro.
Reichel A; Rietzsch H; Köhler HJ; Pfützner A; Gudat U; Schulze J
Exp Clin Endocrinol Diabetes; 1998; 106(3):168-72. PubMed ID: 9710355
[TBL] [Abstract][Full Text] [Related]
33. Systemic allergy to human insulin and its rapid and long acting analogs: successful treatment by continuous subcutaneous insulin lispro infusion.
Castéra V; Dutour-Meyer A; Koeppel M; Petitjean C; Darmon P
Diabetes Metab; 2005 Sep; 31(4 Pt 1):391-400. PubMed ID: 16369203
[TBL] [Abstract][Full Text] [Related]
34. Successful treatment of severe subcutaneous insulin resistance with inhaled insulin therapy.
van Alfen-van der Velden AA; Noordam C; de Galan BE; Hoorweg-Nijman JJ; Voorhoeve PG; Westerlaken C
Pediatr Diabetes; 2010 Sep; 11(6):380-2. PubMed ID: 19761527
[TBL] [Abstract][Full Text] [Related]
35. [Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus].
Rosas Vargas MA; Alvarez Amador M; Alvarez Amador LM; del Río Navarro BE; Avila Castanón L; Sienra Monge JJ
Rev Alerg Mex; 2001; 48(5):129-32. PubMed ID: 11759253
[TBL] [Abstract][Full Text] [Related]
36. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient.
Silva ME; Mendes MJ; Ursich MJ; Rocha DM; Brito AH; Fukui RT; Ruggeri GB; Nery M; Wajchenberg BL
Diabetes Res Clin Pract; 1997 May; 36(2):67-70. PubMed ID: 9229189
[TBL] [Abstract][Full Text] [Related]
37. A case of insulin allergy successfully managed using multihexamer-forming insulin degludec combined with liraglutide.
Fujishiro M; Izumida Y; Takemiya S; Kuwano Y; Takamoto I; Suzuki R; Yamauchi T; Ueki K; Kadowaki T
Diabet Med; 2016 Nov; 33(11):e26-e29. PubMed ID: 26485621
[TBL] [Abstract][Full Text] [Related]
38. Continuous Subcutaneous Insulin Infusion as an Effective Method of Desensitization Therapy for Diabetic Patients with Insulin Allergy: A 4-year Single-center Experience.
Yuan T; Zhao W; Wang L; Dong Y; Li N
Clin Ther; 2016 Nov; 38(11):2489-2494.e1. PubMed ID: 27793354
[TBL] [Abstract][Full Text] [Related]
39. Lipoatrophy associated with rapid-acting insulin analogues in young patients with type 1 diabetes mellitus.
Szypowska A; Skórka A; Pańkowska E
Pediatr Endocrinol Diabetes Metab; 2008; 14(2):117-8. PubMed ID: 18721499
[TBL] [Abstract][Full Text] [Related]
40. Insulin oedema and treatment-induced neuropathy occurring in a 20-year-old patient with Type 1 diabetes commenced on an insulin pump.
Rothacker KM; Kaye J
Diabet Med; 2014 Jan; 31(1):e6-e10. PubMed ID: 23815567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
